ARCHIVES

DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts

This article is from The Cancer Letter archive.

Vol. 05 No. 45 | November 9, 1979

Download PDF Visit The Full Archive

Related Articles

NCI To Offer Compromise On Including “Chop-Like Elements” In CCOP, Agrees Consortia “Appropriate”

May 14, 1982

NCI Moratorium On New OIG Applications; P01 Funding Steadily Drops

May 1, 1992

In Brief: NCI’s Katz Named Director, Arthritis Institute; Hayden Promoted At Bristol-Myers Squibb

July 14, 1995

Amgen, Genzyme, Thoratec Mourn Loss Of Executives Killed In Plane Hijackings.

September 21, 2001

USC wins $3.5 million NCI grant.

April 23, 2004

FCRF Recompetition Notice Of Intent

September 19, 1980